Journal: Gels

Article Title: Novel Gels for Post-Piercing Care: Evaluating the Efficacy of Pranoprofen Formulations in Reducing Inflammation

doi: 10.3390/gels11050334

Figure Lengend Snippet: Permeated ( a , b ) and extracted ( c , d ) amounts of pranoprofen from PF-Gel-Car, PF-Gel-Plu, PF-Gel-Lut, and PF-Gel-Sep on human and cow skin after 24 h of exposure time. ** statistical differences ( p < 0.001), *** statistical differences ( p < 0.0001).

Article Snippet: Previous studies, such as that conducted by Ahmadi et al., have explored the incorporation of nanostructured lipid carriers (NLCs) loaded with pranoprofen (PF) into gels formulated with Carbomer 940 and Sepigel ® 305.

Techniques:

Journal: Antioxidants

Article Title: Catechins within the Biopolymer Matrix—Design Concepts and Bioactivity Prospects

doi: 10.3390/antiox9121180

Figure Lengend Snippet: Effect of encapsulation methodology on the encapsulation efficiency, in vitro release and bioactivity of catechins-loaded biopolymer formulations.

Article Snippet: solid lipid nanocarrier (SLN) nanostructured lipid carrier (NLC) , high-shear homogenisation and ultrasonication technique, unloaded particles size: SLN—206 nm, NLC—216 nm epigallocatechin gallate loaded particles size: SLN 364 nm, NLC 300 nm , EE (SLN) = 83% EE (NLC) = 90% , in simulated gastric medium: burst release, at intestinal conditions: slower, sustained release , low toxicity, biocompatibility, potential for oral preventive and therapeutic supplementation , [ ] .

Techniques: Encapsulation, In Vitro, Activity Assay, Antioxidant Activity Assay, Incubation, Clinical Proteomics, In Vivo, Emulsion, Evaporation, Preserving, Starch, Homogenization, Zeta Potential Analyzer, Liposomes, Concentration Assay, Diffusion-based Assay

Journal: Materials

Article Title: Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery

doi: 10.3390/ma14123332

Figure Lengend Snippet: In vivo studies involving a carrier and targeting agent for the delivery of curcumin for the treatment of AD.

Article Snippet: , 20 mg/kg (applied for 3 weeks) , 75–163 , Nanostructured lipid carrier (NLC) (targeting: lactoferrin) , Sprague-Dawley (SD) rats (injection via caudal veins) , Aβ plaques decreased [ ] .

Techniques: In Vivo, Conjugation Assay, Injection, Membrane, Activity Assay

Journal: Materials

Article Title: Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery

doi: 10.3390/ma14123332

Figure Lengend Snippet: Curcumin nanostructured lipid carrier (Cur-NLC) tissue concentration in the brain with time .

Article Snippet: , 20 mg/kg (applied for 3 weeks) , 75–163 , Nanostructured lipid carrier (NLC) (targeting: lactoferrin) , Sprague-Dawley (SD) rats (injection via caudal veins) , Aβ plaques decreased [ ] .

Techniques: Concentration Assay

Journal: Frontiers in Pharmacology

Article Title: A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies

doi: 10.3389/fphar.2021.639840

Figure Lengend Snippet: Anticancer effects of naringin-based nano-drug delivery systems.

Article Snippet: Nanostructured lipid carrier-containing naringin and coix seed oil , Liver , In vitro; In vivo , HepG2 cell line; BALB-nu nude mice with HepG2 xenografts , 0.39–25 μM; 20 mg/kg , Shanghai Standard Technology Co. Ltd. (Shanghai, China) , (>98%) , Y , 1–10 days , ↓Cell proliferation, ↑apoptosis, ↓cell viability, ↓tumor growth , .

Techniques: Control, In Vitro, In Vivo